Argent Biopharma Limited has released a press release.
September Quarter Activity and Cashflow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- Operations Update - Multiple Revenue Streams Imminent
- New Med Cannabis White Paper Developed with Uni of Sydney
- Strategic Agreement signed with Epilepsy Action Australia
- Appendix 4E and Audited 2016 Financial Report
- Psoriasis and Acne Tests Advancing Ahead of Product Launch
Later from Argent Biopharma
- EU Registration Commenced for CBD Derma Product Sales
- Cleansing Prospectus
- First Major European Sales and Revenue for MGC Derma Range
- New Panax Acquisition Agreement Signed, Settlement Imminent
- MXC Operations Update
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma